Blog

Improving cancer immunotherapy by harnessing new technology – FierceBiotech


FierceBiotech

Improving cancer immunotherapy by harnessing new technology
FierceBiotech
"We think we have developed a straightforward way to modify the really important immunotherapy drugs that work remarkably well in some patients but don't work at all in others," said lead author Jeffrey Hubbell, Ph.D., a professor of tissue engineering

2017-11-08 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.